These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35164453)

  • 21. Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine.
    French ED; Ferkany J; Abreu M; Levenson S
    Neuropharmacology; 1991 Oct; 30(10):1039-46. PubMed ID: 1836840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice.
    O'Neill MF; Shaw G
    Psychopharmacology (Berl); 1999 Aug; 145(3):237-50. PubMed ID: 10494572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice.
    Lapin IP; Rogawski MA
    Behav Brain Res; 1995 Oct; 70(2):145-51. PubMed ID: 8561905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization.
    David HN; Ansseau M; Lemaire M; Abraini JH
    Biol Psychiatry; 2006 Jul; 60(1):49-57. PubMed ID: 16427030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phencyclidine supersensitivity in rats with neonatal dopamine loss.
    Moy SS; Breese GR
    Psychopharmacology (Berl); 2002 May; 161(3):255-62. PubMed ID: 12021828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice.
    Gleason SD; Shannon HE
    Psychopharmacology (Berl); 1997 Jan; 129(1):79-84. PubMed ID: 9122367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of effect of some dopamine and non-dopamine receptor ligands on amphetamine-induced changes in the rat brain neuropeptide Y system.
    Obuchowicz E; Herman ZS
    Pharmacol Rep; 2005; 57(6):850-5. PubMed ID: 16382207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia.
    Adams W; Ayton S; van den Buuse M
    Psychopharmacology (Berl); 2009 Nov; 206(4):665-76. PubMed ID: 19629448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists.
    Javitt DC; Balla A; Burch S; Suckow R; Xie S; Sershen H
    Neuropsychopharmacology; 2004 Feb; 29(2):300-7. PubMed ID: 14560321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional dissociation between serotonergic pathways in dorsal and ventral hippocampus in psychotomimetic drug-induced locomotor hyperactivity and prepulse inhibition in rats.
    Kusljic S; van den Buuse M
    Eur J Neurosci; 2004 Dec; 20(12):3424-32. PubMed ID: 15610175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative trait loci contributing to phencyclidine-induced and amphetamine-induced locomotor behavior in inbred mice.
    Alexander RC; Wright R; Freed W
    Neuropsychopharmacology; 1996 Nov; 15(5):484-90. PubMed ID: 8914121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
    Umino A; Takahashi K; Nishikawa T
    Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retarded acquisition and reduced expression of conditioned locomotor activity in adult rats following repeated early maternal separation: effects of prefeeding, d-amphetamine, dopamine antagonists and clonidine.
    Matthews K; Hall FS; Wilkinson LS; Robbins TW
    Psychopharmacology (Berl); 1996 Jul; 126(1):75-84. PubMed ID: 8853220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of AMPA receptor positive modulators on amphetamine- and dizocilpine-induced locomotion.
    Vanover KE
    Eur J Pharmacol; 1997 Aug; 332(2):115-9. PubMed ID: 9286612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists.
    Chartoff EH; Heusner CL; Palmiter RD
    Neuropsychopharmacology; 2005 Jul; 30(7):1324-33. PubMed ID: 15688082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NMDA receptor antagonists acting at the glycineB site in rat models for antipsychotic-like activity.
    Karcz-Kubicha M; Wedzony K; Zajaczkowski W; Danysz W
    J Neural Transm (Vienna); 1999; 106(11-12):1189-204. PubMed ID: 10651113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute D-amphetamine.
    Polissidis A; Chouliara O; Galanopoulos A; Naxakis G; Papahatjis D; Papadopoulou-Daifoti Z; Antoniou K
    Behav Brain Res; 2014 Aug; 270():261-9. PubMed ID: 24867330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat.
    Hertel P; Mathé JM; Nomikos GG; Iurlo M; Mathé AA; Svensson TH
    Behav Brain Res; 1995 Dec; 72(1-2):103-14. PubMed ID: 8788863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MK801-induced locomotor activity in preweanling and adolescent male and female rats: role of the dopamine and serotonin systems.
    McDougall SA; Apodaca MG; Park GI; Teran A; Baum TJ; Montejano NR
    Psychopharmacology (Berl); 2020 Aug; 237(8):2469-2483. PubMed ID: 32445054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness.
    Breese GR; Knapp DJ; Moy SS
    Neurosci Biobehav Rev; 2002 Jun; 26(4):441-55. PubMed ID: 12204191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.